| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 1,474,000 | 1,432,000 | 1,467,568 | 1,513,954 | | Cost of Revenue | 259,000 | 312,000 | 307,039 | 298,836 | | | Gross Profit | 1,215,000 | 1,120,000 | 1,160,529 | 1,215,118 | | | Operating Expenses | | Research Development | 210,000 | 221,000 | 224,517 | 204,701 | | Selling General and Administrative | 660,000 | 648,000 | 627,170 | 664,216 | | Non Recurring | 25,000 | 37,000 | 439,427 | 7,058,456 | | Others | 63,000 | 62,000 | 61,784 | 60,647 | | | | Total Operating Expenses | 958,000 | 968,000 | 1,352,898 | 7,988,020 | | | | Operating Income or Loss | 257,000 | 152,000 | (192,369) | (6,772,902) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 | 8,000 | 2,743 | 21,247 | | Earnings Before Interest And Taxes | 260,000 | 160,000 | (189,626) | (6,751,655) | | Interest Expense | 31,000 | 32,000 | 6,913 | 6,511 | | Income Before Tax | 229,000 | 128,000 | (196,539) | (6,758,166) | | Income Tax Expense | 67,000 | 42,000 | 33,175 | 31,620 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 150,000 | 73,000 | (249,378) | (6,806,257) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 150,000 | 73,000 | (249,378) | (6,806,257) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $150,000 | $73,000 | ($249,378) | ($6,806,257) |
|
0.51% Nasdaq 
Income Statement
